GENPHARMASEC LIMITED Share Price

GENPHARMASEC LIMITED Share Price

BSE: 531592
|
Dyes & Pigments

₹ 0.99

-₹0.01 (-1%)
1D
Last updated 14 Oct, 2026, 10:07 IST

GENPHARMASEC LIMITED Share Price Today

As of 14 Oct 2026, GENPHARMASEC LIMITED share price is ₹0.99. The stock opened at ₹1.02, compared to its previous close of ₹1.00. During today's trading session, GENPHARMASEC LIMITED share price moved in the range of ₹0.99 to ₹1.02, with an average price of ₹1.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹0.75 and a high of ₹1.85.

₹0.99
1.00% down today
₹1.02
1D LOW
1D HIGH

GENPHARMASEC LIMITED Returns Calculator

Volume
52,854
Average traded price
₹1.00
Last traded time
10:07:45 14 Oct
Last traded quantity
11,775
Circuit
L
H
₹0.80
₹1.20
52-week
L
H
₹0.75
₹1.85
Mkt Cap Cr
55.37
P/E
-100.0
P/B
0.84
ROA
-0.6%
ROE
2.42%
ROCE
2.18%
Quick Ratio
1.42
EV/EBITDA
19.72
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Genpharmasec has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Genpharmasec appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Genpharmasec earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Adani Enterprises3,56,371.7047.43.762.76%3.93%5.11%0.7218.13
Aegis Logistics50,887.9834.488.410.19%14.83%15.38%1.6721.21
PREMIER ENERGIES LIMITED41,218.8024.639.5715.43%35.05%26.37%1.215.39
Redington30,657.2820.323.014.45%14.67%15.8%1.0612.26
HONASA CONSUMER LIMITED15,399.7561.7510.911.91%14.16%17.48%1.440.23
AUGMONT ENTERPRISES LTD12,533.250.00.035.03%53.18%70.24%2.710.0
LLOYDS ENTERPRISES LTD10,941.6239.322.643.28%6.84%10.45%2.4330.54
SG MART LIMITED9,649.7377.636.045.53%6.96%10.42%2.3441.58
MMTC8,218.5018.393.8816.0%4.72%7.79%3.48.88
GNG ELECTRONICS LIMITED7,824.0455.9310.5111.36%17.42%15.97%0.937.31

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About GENPHARMASEC LIMITED

GENPHARMASEC LIMITED Share Price
ISIN
INE861N01036
Sector Market Cap
₹ 55.37 Cr

Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.

GENPHARMASEC LIMITED Financial Highlights

  • Revenue: GENPHARMASEC LIMITED reported revenue of ₹143.10 crore in FY26 vs ₹36.78 crore in FY25. It showed an increase of 289.07% on a yearly basis.
  • Operating Profit: GENPHARMASEC LIMITED reported an operating profit of ₹0.97 crore in FY26 vs ₹2.21 crore in FY25. It showed a decrease of 56.11% on a year-on-year basis.
  • Net Profit: GENPHARMASEC LIMITED reported a net profit of ₹0.56 crore in FY26 vs ₹1.56 crore in FY25. It showed a decrease of 64.10% on a yearly basis.

GENPHARMASEC LIMITED Quarterly Result Highlights

  • GENPHARMASEC LIMITED reported revenue of ₹50.08 crore in Jun 2026, compared with ₹56.45 crore in Mar 2026, representing a decrease of 11.28% on a quarter-on-quarter (QoQ) basis.
  • GENPHARMASEC LIMITED reported an operating profit of ₹0.26 crore in Jun 2026, compared with ₹1.85 crore in Mar 2026, representing a decrease of 85.95% on a quarter-on-quarter (QoQ) basis.
  • GENPHARMASEC LIMITED reported a loss of ₹0.17 crore in Jun 2026, compared with ₹1.35 crore in Mar 2026, reflecting a decrease of 112.59% on a QoQ basis.
  • The earnings per share (EPS) of GENPHARMASEC LIMITED stood at ₹0.01 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
29.98%
FII
0.00%
Other DII
0.00%
Retail and other
70.02%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
--
1 week
-9.09%
1 month
-14.53%
1 year
-43.18%
3 years
-75.49%
5 years
-86.96%
Day
Open / Close
Change %
13 Oct 26
₹1.00 / ₹1.00
0.00%
12 Oct 26
₹0.98 / ₹1.00
0.00%
09 Oct 26
₹1.07 / ₹1.00
-4.76%
08 Oct 26
₹1.11 / ₹1.05
-3.67%
Show more

GENPHARMASEC LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹139.94₹33.72₹30.41₹25.52
Other Income₹3.16₹3.06₹0.66₹0.10
Total Revenue₹143.09₹36.78₹31.06₹25.62
Total Expenses₹142.12₹34.57₹30.81₹25.33
Profit Before Tax₹0.97₹2.21₹0.25₹0.28
Tax₹0.41₹0.65₹0.42-₹0.84
Profit After Tax₹0.56₹1.56-₹0.17₹1.12
EPS - Basic₹0.01₹0.03-₹0.01₹0.04
EPS - Diluted₹0.01₹0.03-₹0.01₹0.04

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.97₹2.21₹0.25₹0.28
Income before WC changes₹2.93₹0.98₹0.64₹0.45
Change in Assets-₹42.82-₹4.00-₹4.78₹1.05
Change in Liabilities₹23.32₹6.05₹1.24-₹4.82
Change in WC-₹19.49₹2.05-₹3.54-₹3.77
Cash flow from Operations-₹17.55₹2.95-₹2.95-₹3.06
Cash flow from Investing₹13.26-₹4.22-₹28.06₹0.36
Cash flow from Financing₹3.92-₹1.25₹47.85₹3.08
Total Cash Flow-₹0.37-₹2.52₹16.84₹0.39
Cash (Start of the year)₹1.34₹3.17₹1.99₹1.61
Cash (End of the year)₹0.97₹0.65₹18.83₹1.99

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹57.63₹53.47₹30.15₹0.95
Current Assets₹80.52₹26.42₹40.97₹18.93
Total Assets₹138.15₹79.89₹71.13₹19.88
Current Liabilities₹47.03₹9.84₹2.70₹2.06
Net Current Asset₹33.50₹16.59₹38.27₹16.87
Non-Current Liabilities₹25.48₹4.78₹3.89₹2.48
Equity Capital₹65.64₹65.28₹64.53₹15.33
Total Equity & Liabilities₹138.15₹79.89₹71.13₹19.88

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹131.35₹32.96₹30.41₹25.52
Other Income₹4.87₹3.43₹0.72₹0.10
Total Revenue₹136.22₹36.39₹31.12₹25.62
Total Expenses₹129.78₹32.61₹30.66₹25.33
Profit Before Tax₹6.44₹3.78₹0.47₹0.28
Tax₹0.99₹0.98₹0.42-₹0.84
Profit After Tax₹5.45₹2.80₹0.05₹1.12
EPS - Basic₹0.10₹0.05₹0.00₹0.04
EPS - Diluted₹0.10₹0.05₹0.00₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.44₹3.78₹0.47₹0.28
Income before WC changes₹4.00₹0.49₹0.76₹0.45
Change in Assets-₹25.48-₹5.31-₹4.23₹1.05
Change in Liabilities₹24.22₹5.82₹1.23-₹4.82
Change in WC-₹1.25₹0.51-₹2.99-₹3.77
Cash flow from Operations₹1.93₹0.96-₹2.27-₹3.06
Cash flow from Investing-₹1.64-₹2.92-₹29.03₹0.36
Cash flow from Financing-₹0.02-₹0.44₹47.89₹3.08
Total Cash Flow₹0.27-₹2.39₹16.59₹0.39
Cash (Start of the year)₹0.52₹2.92₹1.99₹1.61
Cash (End of the year)₹0.79₹0.52₹18.58₹1.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹48.29₹52.16₹30.44₹0.95
Current Assets₹61.77₹26.94₹40.04₹18.93
Total Assets₹110.06₹79.09₹70.47₹19.88
Current Liabilities₹33.80₹9.26₹2.70₹2.06
Net Current Asset₹27.97₹17.68₹37.34₹16.87
Non-Current Liabilities₹4.77₹3.29₹3.21₹2.48
Equity Capital₹71.50₹66.55₹64.57₹15.33
Total Equity & Liabilities₹110.06₹79.09₹70.47₹19.88
* All values are in INR Crore
Qty
Bid
42427
0.99
5950
0.98
2350
0.97
12551
0.96
11961
0.95
Ask
Qty
1.01
1000
1.02
160089
1.03
11009
1.05
236000
1.06
10000
Bid Total: 75239
Ask Total: 418098
Buy orders: 15%
Sell orders: 85%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.03
Neutral
ATR (14)
0.07
Neutral
STOCH(9,6)
41.67
Neutral
STOCH RSI (14)
10.44
Bullish
ADX(9)
37.25
Bearish
UO(9)
50.79
Neutral
ROC(12)
-9.82
Bearish
WillR(14)
-61.54
Neutral
Period
Simple value
Exponential vaue
5D
1.03
1.02
10D
1.07
1.05
20D
1.1
1.08
50D
1.09
1.09
100D
1.1
1.1
Volume trend — traded volume by day
14 Oct0L
13 Oct5L
12 Oct4L
9 Oct8L
8 Oct4L
7 Oct0L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GENPHARMASEC LIMITED Share Price
GENPHARMASEC LIMITED
Dyes & Pigments
Add Stock
Add Another

GENPHARMASEC LIMITED Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.